Recent Study on BIA-ALCL RisksSince my last article on this topic, "What is the Risk of Death Due to Breast Implant-Associated Lymphoma?," additional information on the risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL) has been released. The most recent study, titled "Breast Implants and the Risk of Anaplastic Large-Cell … [Read more...]
Breast Implant-Associated Lymphoma Diagnoses on the Rise
On October 18, 2017, the JAMA Surgery journal published an article titled "Breast Implant–Associated Anaplastic Large Cell Lymphoma A Systematic Review," in which they discuss the rate of occurrence of the condition. The article served as a review of 115 articles on the topic of breast implant–associated anaplastic large cell lymphoma (BIA-ALCL) … [Read more...]
What is the Risk of Death Due to Breast Implant-Associated Lymphoma?
On August 23, 2017, the Aesthetic Surgery Journal distributed a press release concerning a recent study on the risk of death from Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). To provide some background information, BIA-ALCL is a rare non-Hodgkin lymphoma of T-cell origin that is typically found in the effusion fluid … [Read more...]
Breast Implants and Lymphoma: Who’s to Blame?
As previously discussed in my articles, "Breast Implants Linked to Rare Lymphoma Blood Cancer" and "Breast Implant Lymphoma: Causes Uncertain, but Costs Undeniable, the FDA recently updated their 2011 report of the association between breast implants and anaplastic large-cell lymphoma (ALCL), providing additional information on this rare form of … [Read more...]
Breast Implant Lymphoma: Causes Uncertain, but Costs Undeniable
As news of the possible link between breast implants and a rare form of lymphoma cancer has spread, more theories about how it develops have come to light. One such theory is outlined in the excerpt, below, from the article, "Increase in Australian cancer cases linked to breast implants": Dr. Gazi Hussain, Vice President of the Australian … [Read more...]
Breast Implants Lymphoma Cancer: Diagnosis And Treatment Developments
The medical literature about breast implant-associated ALCL (BIA-ALCL) grew considerably in 2015, and reflected a better understanding of the diagnosis and treatment aspects of this rare form of lymphoma. In February 2015 this article, "Breast Implant-associated Anaplastic Large Cell Lymphoma: Updated Results from a Structured Expert … [Read more...]
March 2017 FDA Report: Breast Implants Linked To Lymphoma Blood Cancer
You may have heard about the March 2017 FDA update report concerning a little-known and rare type of lymphoma, or blood cancer, which has been developing in some women who have had breast implant procedures done for augmentation or reconstruction purposes. From this March 21, 2017 article, "9 Deaths Are Linked to Rare Cancer From Breast … [Read more...]
Breast Implants Linked to Rare Lymphoma Blood Cancer
The FDA first identified a possible link between breast implants and anaplastic large cell lymphoma (ALCL) in their report from January 2011. ALCL is a rare type of blood cancer that is classified as a non-Hodgkin lymphoma, and one of the subtypes of T-cell lymphoma. It can initially appear either in the skin, in the lymph nodes, or in organs … [Read more...]